Clinical Trials in Ohio

Showing 6081-6100 of 20,938 trials

COMPLETEDPhase 118 miles

Investigating the Clinical Impact of a Novel Adipose Allograft Matrix on Knee Fat Pad Impingement Treatment

NCT05880888

This study is to assess the effect of Renuva® on fat pad regeneration in patients with Fat pad Impingement

Fat Pad Syndrome

Ohio State University3 participantsStarted Apr 2023

Columbus, Ohio, United States • Lewis Center, Ohio, United States

TERMINATEDPhase 332 miles

Extension to Study on Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain

NCT04372121

The primary objective of this extension study is to assess the maintenance of efficacy of linzagolix administered orally once daily for up to an additional 6 months (for up to 12 months of treatment in total) in women who have already completed 6 months of linzagolix treatment at a dose of 75 mg alone or of 200 mg in combination with ABT (E2 1 mg / NETA 0.5 mg), in the management of moderate to severe endometriosis-associated pain (EAP) in women with surgically confirmed endometriosis.

Endometriosis

Kissei Pharmaceutical Co., Ltd.30 participantsStarted Mar 2020

Little Rock, Arkansas, United States • Norwalk, California, United States • Greenwood Village, Colorado, United States +22 more locations

Investigating the Clinical Impact of a Novel Adipose Allograft Matrix on Knee Fat Pad Impingement Treatment

Extension to Study on Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain

Find Trials by Condition in Ohio

αβT Cell/CD19+ B Cell Depletion for Alternative Donor Allogeneic Hematopoietic Cell Transplantation (HSCT)

Supplemental Citicoline Administration to Reduce Lung Injury Efficacy Trial (SCARLET)

Open-Label Extension Study of DCCR in Patients With Prader-Willi Syndrome

Cryopreserved Human Umbilical Cord (TTAX01) for Late Stage, Complex Non-healing Diabetic Foot Ulcers (AMBULATE DFU II)

Study of Once-Daily Oral RGT001-075 Compared With Placebo in Adults With Obesity or Are Overweight With Weight-Related Health Conditions

The DETOUR 2 Clinical Trial

EDIT-301 for Autologous Hematopoietic Stem Cell Transplant (HSCT) in Participants With Transfusion-Dependent Beta Thalassemia (TDT)

Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain.

Strategy to Avoid Excessive Oxygen in Major Burn Patients

Study to Evaluate the Safety and Efficacy of SPR001 in Subjects With Classic Congenital Adrenal Hyperplasia

Trial to Assess Safety and Efficacy of Lenvatinib (18 mg vs. 14 mg) in Combination With Everolimus in Participants With Renal Cell Carcinoma

Study Using CABENUVA™ for the Treatment of Human Immunodeficiency Virus (HIV)-1, Administered in Infusion Centers (IC) or Alternate Sites of Administration (ASA) in the United States (U.S.)

A Study on Safety and Immune Response of Investigational RSV OA Vaccine in Combination With Herpes Zoster Vaccine in Healthy Adults

To Evaluate the Efficacy, Safety, and Tolerability of BBT-877 in Patients With IPF

EFS of Bioabsorbable Implant for NSD

XEN1101 for Major Depressive Disorder

Tissue Repair Gel in Venous Leg Ulcers in AU/US

A Study to Evaluate Safety, Tolerability and Preliminary Efficacy of FP-1305 in Cancer Patients (MATINS)